Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Prattes, J; Schilcher, G; Krause, R.
Reliability of serum 1,3-beta-D-glucan assay in patients undergoing renal replacement therapy: a review of the literature.
Mycoses. 2015; 58(1):4-9
Doi: 10.1111/myc.12267
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Krause Robert
- Prattes Jürgen
- Co-Autor*innen der Med Uni Graz
- Schilcher Gernot
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The serum 1,3-beta-D-glucan (BDG) test is a pan-fungal serum marker considered to detect the majority of pathogenic fungi, including Aspergillus spp. and Candida spp. For this review we searched for publications dealing with serum BDG levels in patients undergoing renal replacement therapy (RRT). The influence of various different membrane materials used for RRTs in these publications on serum BDG has been reviewed. We found that unmodified cellulose containing membranes increased the serum BDG levels highly, whereas conflicting results have been observed for modified cellulose containing materials. Synthetic materials (e.g. polysuflone) had no influence on serum BDG levels in the majority of the reviewed publications. © 2014 Blackwell Verlag GmbH.
- Find related publications in this database (using NLM MeSH Indexing)
- Antigens, Fungal - blood
- Biomarkers - blood
- Cellulose -
- False Positive Reactions -
- Female -
- Humans -
- Male -
- Mycoses - diagnosis
- Renal Dialysis - instrumentation
- Reproducibility of Results -
- beta-Glucans - blood
- Find related publications in this database (Keywords)
- 1
- 3-Beta-d-glucan
- renal replacement therapy